Form 4 for ENVA Enova International, Inc.
Accepted 2022-02-11 00:00:00 ET · period of report 2021-02-09 · accession 0000899243-22-005958 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-11 | 2022-02-09 | ENVA | Fisher David | CEO, Dir | F - Tax | $44.47 | -22.0K | 507.0K | -4% | -$978.2K |
| DM | 2022-02-11 | 2022-02-09+ | ENVA | Fisher David | CEO, Dir | M - OptEx | $23.14 | -68.1K | 1.12M | -6% | -$1.58M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.00001 per share | 2022-02-09 | F | D | 12,663 | $44.47 | 494,323 | D | — | — | (F1) This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person. (F2) Includes timed-based restricted stock units previously granted to the Reporting Person. |
| 2 | Common | Common stock, par value $0.00001 per share | 2022-02-09 | F | D | 9,333 | $44.47 | 506,986 | D | — | — | (F1) This transaction represents the withholding by Enova International, Inc. ("Issuer") of Issuer's shares to pay taxes in connections with the vesting of restricted stock units on the Transaction Date. The timing and amount of the transaction were determined by the terms of the applicable restricted stock and were not within the control of the Reporting Person. (F2) Includes timed-based restricted stock units previously granted to the Reporting Person. |
| 3 | Derivative | Stock Option (right to buy) with limited SAR | 2022-02-09 | M | D | 100 | $23.14 | 1,186,872 | D | $45.00 · — to 2022-03-09 | 100 Common stock, par value $0.00001 per share | (F3) The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. (F4) The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. (F5) The options vested in substantially equal one-third increments on each of the following dates as long as grantee served as an employee of Issuer or an affiliate thereof through the applicable vesting date March 20, 2015, March 20, 2016 and March 20, 2017. |
| 4 | Derivative | Stock Option (right to buy) with limited SAR | 2022-02-10 | M | D | 68,022 | $23.14 | 1,118,850 | D | $45.79 · — to 2022-03-09 | 68,022 Common stock, par value $0.00001 per share | (F3) The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. (F4) The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. (F6) The price reported in Column 2 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $46.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. (F5) The options vested in substantially equal one-third increments on each of the following dates as long as grantee served as an employee of Issuer or an affiliate thereof through the applicable vesting date March 20, 2015, March 20, 2016 and March 20, 2017. |